MAPKAPK5 and obesity due to melanocortin 4 receptor deficiency: The potential important aspects of this study provide useful information with clinical implications in which specific targets of PRAK could serve as effective therapies to treat diabetes, metabolic disorders, obesity, and cardiovascular disease.